• Arcutis Biotherapeutics appointed Rob Scott to its board of directors, effective October 23, 2026.
• Scott previously served as AbbVie's chief medical officer before retiring in 2020. He has more than 40 years of pharmaceutical industry experience.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610280900PRIMZONEFULLFEED9854827) on October 28, 2026, and is solely responsible for the information contained therein.